Loading
A phase 3 trial of durvalumab in lung cancer, run by Association NVALT Studies, active but no longer recruiting.
Durvalumab and Low-dose PCI vs Durvalumab and Observation in Radically Treated Patients With Stage III NSCLC (NVALT28) is a phase 3, randomised interventional study registered as NCT04597671 by Association NVALT Studies, with a registry enrolment figure of 170 participants, started 2021-12-06 and due to reach its primary completion in 2028-12. Interventions recorded: Durvalumab; low-dose PCI. Conditions listed: Carcinoma, Non-Small-Cell Lung. Primary outcome: Reduction of incidence of brain metastases. Lung eligibility wording from the registry: "TNM8 stage IIIA, IIIB or IIIC non-small cell lung cancer before start of concurrent chemoradiotherapy (preferentially histology; cytology is allowed)". Sites: Netherlands. No results are recorded here; the registry entry is the source.
Shares Unresectable stage III non-small-cell lung cancer, Lung cancer trials open today (registry snapshot), IMRT / IGRT (modern external beam) and the tag lung-deep-dive.
Shares Unresectable stage III non-small-cell lung cancer, Lung cancer trials open today (registry snapshot), IMRT / IGRT (modern external beam) and the tag lung-deep-dive.
Shares Unresectable stage III non-small-cell lung cancer, Lung cancer trials open today (registry snapshot), IMRT / IGRT (modern external beam) and the tag lung-deep-dive.
Shares Unresectable stage III non-small-cell lung cancer, Lung cancer trials open today (registry snapshot), IMRT / IGRT (modern external beam) and the tag lung-deep-dive.
Shares Unresectable stage III non-small-cell lung cancer, Lung cancer trials open today (registry snapshot), IMRT / IGRT (modern external beam) and the tag lung-deep-dive.
Shares Unresectable stage III non-small-cell lung cancer, Lung cancer trials open today (registry snapshot), IMRT / IGRT (modern external beam) and the tag lung-deep-dive.
Shares Unresectable stage III non-small-cell lung cancer, Lung cancer trials open today (registry snapshot), IMRT / IGRT (modern external beam) and the tag lung-deep-dive.
Shares Unresectable stage III non-small-cell lung cancer, Lung cancer trials open today (registry snapshot), IMRT / IGRT (modern external beam) and the tag lung-deep-dive.